Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/25171
Title: A budget impact analysis of Spiromax(®) compared with Turbuhaler(®) for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions.
Authors: 
Keywords: 
Issue Date: 2016
Citation: Clinicoecon Outcomes Res.2016;(8):435-44
Abstract: To assess the economic impact of the introduction of DuoResp(®) Spiromax(®) by focusing on a potential improvement in the inhalation technique to strengthen medication adherence for the treatment of moderate to severe asthmatics in Spain and five Spanish regions including Andalusia, Catalonia, Galicia, Madrid, and Valencia.
PMID: 27660476
URI: https://hdl.handle.net/20.500.12530/25171
Rights: openAccess
ISSN: 1178-6981
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC5019164.pdf261,35 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.